---
document_datetime: 2023-09-21 19:30:01
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/luxturna-epar-all-authorised-presentations_en.pdf
document_name: luxturna-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.6672633
conversion_datetime: 2025-12-27 14:24:28.962043
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength        | Pharmaceutical form                                | Route of administration   | Immediate Packaging                          | Content (concentration)              | Pack size                            |
|------------------|-------------------|-----------------|----------------------------------------------------|---------------------------|----------------------------------------------|--------------------------------------|--------------------------------------|
| EU/1/18/1331/001 | Luxturna          | 5 x 10 12 vg/ml | Concentrate and solvent for solution for injection | Subretinal use            | Concentrate: vial (COC); Solvent: vial (COC) | Concentrate: 0.5 ml; Solvent: 1.7 ml | 1 concentrate vial + 2 solvent vials |